首页> 外文会议>2011 IEEE International Ultrasonics Symposium >Delivery of drug-loaded microbubbles and disruption of blood-brain barrier by focused ultrasound in a xenograft rat glioma model
【24h】

Delivery of drug-loaded microbubbles and disruption of blood-brain barrier by focused ultrasound in a xenograft rat glioma model

机译:在异种移植大鼠神经胶质瘤模型中通过聚焦超声递送载药微泡并破坏血脑屏障

获取原文
获取原文并翻译 | 示例

摘要

Glioblastoma multiforme (GBM) is a highly malignant brain tumor. The blood-brain barrier (BBB) provides a major obstacle to chemotherapy since therapeutic doses cannot be achieved by traditional drug delivery without severe systemic cytotoxic effects. Recently, microbubble (MB)-enhanced focused ultrasound (FUS) was shown to temporally and locally disrupt the BBB thereby enhancing drug delivery into brain tumors. Here we propose the concept of smart, multifunctional MBs capable of facilitating FUS-induced BBB disruption while serving as drug carrying vehicles and protecting drugs from rapid degradation. The designed MBs had a high loading capacity (efficiency of 68.01 ± 4.35 %) for 1,3-bis(2-chloroethyl)-1- nitrosourea (BCNU). When combined with FUS (1-MHz), these BCNU-MBs facilitated local BBB disruption and simultaneously released BCNU at the target site, thus increasing local BCNU deposition. And accumulation of BCNU in the liver was reduced 5-fold due to the slow reticuloendothelial system uptake of BCNU-MBs. In tumor-bearing animals, BCNU-MBs with FUS controlled tumor progression (915.3 % to 39.6 %) and improved median survival (29 days to 32.5 days). This study provides a new approach for designing multifunctional MBs to facilitate FUS-mediated chemotherapy for brain tumor treatment.
机译:多形胶质母细胞瘤(GBM)是一种高度恶性的脑瘤。血脑屏障(BBB)为化学疗法提供了主要障碍,因为如果没有严重的全身细胞毒性作用,传统药物无法达到治疗剂量。最近,微泡(MB)增强聚焦超声(FUS)已显示出暂时和局部破坏血脑屏障,从而增强了向脑肿瘤的药物递送。在这里,我们提出了智能多功能MB的概念,它可以促进FUS诱导的BBB破坏,同时充当载药载体并保护药物免于快速降解。设计的MBs对1,3-双(2-氯乙基)-1-亚硝基脲(BCNU)具有很高的负载能力(效率为68.01±4.35%)。当与FUS(1-MHz)结合使用时,这些BCNU-MB促进了局部BBB的破坏,同时在目标部位释放了BCNU,从而增加了局部BCNU的沉积。由于网状内皮系统对BCNU-MBs的吸收较慢,肝脏中BCNU的积累减少了5倍。在荷瘤动物中,具有FUS的BCNU-MBs控制了肿瘤的进展(915.3%至39.6%)并提高了中位生存期(29天至32.5天)。这项研究提供了一种设计多功能MB的新方法,以促进FUS介导的化学疗法治疗脑肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号